Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COBRRA Pilot: Rivaroxaban vs Apixaban for Acute VTE
NCT02559856Phase 4Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- May 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in venous thromboembolism (VTE) comparing Apixaban with Rivaroxaban (2 arms). Primary endpoints: Number of Patients Screened Who Are Eligible to Participate in the Trial, Number of Eligible Patients Who Consent to Participate in the Trial and 2 more. Started May 2016; status: completed.
02
Drugs
apixabanrivaroxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02559856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02559856.